Routy Jp

598 total citations
20 papers, 409 citations indexed

About

Routy Jp is a scholar working on Virology, Infectious Diseases and Emergency Medicine. According to data from OpenAlex, Routy Jp has authored 20 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Virology, 11 papers in Infectious Diseases and 5 papers in Emergency Medicine. Recurrent topics in Routy Jp's work include HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (8 papers). Routy Jp is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (8 papers). Routy Jp collaborates with scholars based in Canada, France and United States. Routy Jp's co-authors include Cécile Tremblay, Jonathan B. Angel, Joel Singer, Danielle Rouleau, Norbert Gilmore, Danuta Radzioch, Cynthia Kanagaratham, Petronela Ancuța, M.H. Patel and Ido P. Kema and has published in prestigious journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Clinical & Experimental Immunology and HIV Medicine.

In The Last Decade

Routy Jp

20 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Routy Jp Canada 10 266 209 133 64 63 20 409
Marie Fuerst United States 7 278 1.0× 145 0.7× 193 1.5× 93 1.5× 60 1.0× 11 384
Lourdes Adamson United States 11 330 1.2× 244 1.2× 87 0.7× 99 1.5× 60 1.0× 18 416
Heather A. Pilch-Cooper United States 7 237 0.9× 122 0.6× 159 1.2× 83 1.3× 116 1.8× 8 351
Randall Tressler United States 7 239 0.9× 219 1.0× 46 0.3× 75 1.2× 90 1.4× 11 327
Yan‐Mei Jiao China 13 161 0.6× 164 0.8× 167 1.3× 94 1.5× 55 0.9× 48 425
Chris A. R. Baker United States 13 214 0.8× 117 0.6× 240 1.8× 84 1.3× 22 0.3× 21 422
Kawthar Machmach Spain 11 236 0.9× 92 0.4× 209 1.6× 86 1.3× 40 0.6× 20 346
Leslie R. Cockerham United States 10 255 1.0× 200 1.0× 137 1.0× 124 1.9× 105 1.7× 11 403
Anne-Sophie Liovat France 7 240 0.9× 100 0.5× 213 1.6× 80 1.3× 65 1.0× 7 342
Jean-Pierre Routy Canada 7 196 0.7× 95 0.5× 193 1.5× 75 1.2× 57 0.9× 12 310

Countries citing papers authored by Routy Jp

Since Specialization
Citations

This map shows the geographic impact of Routy Jp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Routy Jp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Routy Jp more than expected).

Fields of papers citing papers by Routy Jp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Routy Jp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Routy Jp. The network helps show where Routy Jp may publish in the future.

Co-authorship network of co-authors of Routy Jp

This figure shows the co-authorship network connecting the top 25 collaborators of Routy Jp. A scholar is included among the top collaborators of Routy Jp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Routy Jp. Routy Jp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moreno, Santiago, Carlo Federico Perno, Patrick Mallon, et al.. (2019). Two‐drug vs. three‐drug combinations for HIV‐1: Do we have enough data to make the switch?. HIV Medicine. 20(S4). 2–12. 62 indexed citations
2.
Chen, Jun, Yinzhong Shen, Tangkai Qi, et al.. (2018). Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV‐infected patients with cryptococcal meningitis. HIV Medicine. 20(1). 69–73. 7 indexed citations
3.
Cheng, Xinqi, Evelyn Hsieh, Qiang Fu, et al.. (2018). Prospective plasma efavirenz concentration assessment in Chinese HIV‐infected adults enrolled in a large multicentre study. HIV Medicine. 19(7). 440–451. 12 indexed citations
4.
Cao, Wei, et al.. (2016). Antiretroviral Therapy in Primary HIV-1 Infection: Influences on Immune Activation and Gut Mucosal Barrier Dysfunction.. PubMed. 17(3). 135–46. 9 indexed citations
5.
Isitman, Gamze, Rujun Song, Sandrina DaFonseca, et al.. (2016). The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context ofin-vitroHIV infection. Clinical & Experimental Immunology. 186(3). 336–346. 5 indexed citations
6.
Patel, M.H., Ido P. Kema, Kishanda Vyboh, et al.. (2014). Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection. Clinical & Experimental Immunology. 178(1). 102–111. 58 indexed citations
7.
Jp, Routy, Jonathan B. Angel, M.H. Patel, et al.. (2014). Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV‐infected patients receiving antiretroviral therapy. HIV Medicine. 16(1). 48–56. 50 indexed citations
8.
Jp, Routy, Jonathan B. Angel, Benoît Trottier, et al.. (2012). Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV‐1 reservoirs: results from a multicentre randomized clinical study. HIV Medicine. 13(5). 291–296. 89 indexed citations
9.
Chamberland, Annie, Mohamed Sylla, Mohamed‐Rachid Boulassel, et al.. (2011). Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection. International Journal of STD & AIDS. 22(3). 146–150. 10 indexed citations
10.
Roger, Michel, et al.. (2009). 162 Transmission Networks of Drug Resistance Acquired in Primary/Early Stage HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(Supplement 2). 2 indexed citations
12.
Mercier, François, et al.. (2008). Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Rα on central and effector memory CD4+ and CD8+ T cell subsets. Clinical & Experimental Immunology. 152(1). 72–80. 36 indexed citations
14.
Boulassel, Mohamed‐Rachid, Danielle Rouleau, Cécile Tremblay, et al.. (2003). Changes in immunological and virological parameters in HIV‐1 infected subjects following leukapheresis. Journal of Clinical Apheresis. 18(2). 55–60. 29 indexed citations
16.
Jp, Routy, et al.. (1990). [HIV-1 primo-infection and cytomegalovirus reactivation in 2 intravenous drug users. Prognostic significance].. PubMed. 141(2). 194–5. 1 indexed citations
17.
Jp, Routy, et al.. (1989). [Efficacy of long-acting somatostatin in refractory diarrhea in 2 patients with AIDS].. PubMed. 140(8). 737–8. 1 indexed citations
18.
Jp, Routy, et al.. (1988). [Atrioventricular blocks in relapsing polychondritis. Cases of complete block explored by endocavitary tract].. PubMed. 17(1). 36–36. 5 indexed citations
19.
Jp, Routy, et al.. (1985). [Fatal complication during treatment with elliptinium acetate].. PubMed. 14(2). 104–104. 1 indexed citations
20.
Jp, Routy, et al.. (1985). [Hereditary coproporphyria with hyponatremia complicated by centropontine myelinolysis].. PubMed. 14(25). 1383–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026